ask="49.00"
ask_size="1100"
average_daily_volume="394829"
bid="40.00"
bid_size="100"
book_value="14.89"
change="+0.05"
change_from_200_day_moving_average="-4.73"
change_from_50_day_moving_average="-2.61"
change_from_52_week_high="-15.55"
change_From_52_week_low="17.42"
change_in_percent="+0.11%"
close="45.43"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="8.95"
ebitda="267.62M"
eps_estimate_current_year="-2.27"
eps_estimate_next_quarter="-0.74"
eps_estimate_next_year="-3.15"
ex_dividend_date="N/A"
float_shares="24015000"
high="46.11"
high_52_weeks="60.98"
last_trade_date="2/8/2017"
last_trade_price="45.43"
last_trade_size="14215"
last_trade_time="4:00pm"
low="44.86"
low_52_weeks="28.01"
market_capitalization="1.23B"
moving_average_200_day="50.16"
moving_average_50_day="48.04"
name="Five Prime Therapeutics
Inc."
notes="N/A"
one_year_target_price="60.17"
open="45.03"
pe_ratio="5.08"
peg_ratio="0.34"
percent_change_from_200_day_moving_average="-9.43%"
percent_change_from_50_day_moving_average="-5.44%"
percent_change_from_52_week_high="-25.50%"
percent_change_from_52_week_low="+62.19%"
previous_close="45.38"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.05"
price_per_sales="3.19"
revenue="385.77M"
shares_outstanding="27138000"
short_ratio="6.16"
stock_exchange="NMS"
symbol="FPRX"
volume="334698"
weeks_range_52="28.01 - 60.98"
